Sort
64,565 grants matching “drug discovery”
Cancer Center Administration
$673,711Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2024 · CA
Drug Abuse: Discovering Ligands for Pertinent GPCRs
$673,672Marc G. Caron · Duke University · P30 · FY2011 · DA
Reconfigurable microfluidic assay platform for molecular
$673,667Peter Russell Charles Gascoyne · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · EB
Effects of Interferon on primate lentiviruses
$673,658Theodora Hatziioannou · Rockefeller University · R01 · FY2025 · AI
ncRNA: structure, function and inhibition
$673,638Gabriele Varani · University Of Washington · R35 · FY2024 · GM
Scalable platform for optimizing human cardiac tissue engineering via optical pacing and on-demand oxygenation
$673,613Emilia Entcheva · George Washington University · R01 · FY2022 · HL
Bronchiolitis Obliterans: Discovery and Therapy
$673,610Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2022 · HL
Senior Leadership
$673,582Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2012 · CA
New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior
$673,451Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
ncRNA: structure, function and inhibition
$673,426Gabriele Varani · University Of Washington · R35 · FY2025 · GM
UC San Diego Clinical and Translational Research Institute
$673,418Colin A Depp · University Of California, San Diego · TL1 · FY2015 · TR
Biology and vulnerabilities of POU2F3+ tuft cell-like carcinomas
$673,208Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
Biomolecular Recognition and Binding Mechanisms
$673,153Ruth Nussinov · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Mechanism Based Inhibition of M Tuberculosis Enzymes
$673,080John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2010 · AI
Discovery & Synthesis Chemputer: An intelligent universal system for automated chemical synthesis and discovery across different hardware and scales
$673,055Lee Cronin · University Of Glasgow · UG3 · FY2023 · TR
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
$672,991Daniel J. Powell · University Of Pennsylvania · R01 · FY2022 · CA
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2
$672,866Susan Ruth Schwab · New York University School Of Medicine · R01 · FY2020 · AI
Epigenetic Modifications of BDNF and trkB Genes Underlie Pain Plasticity
$672,810Susan G Dorsey · University Of Maryland Baltimore · R01 · FY2011 · NR
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
$672,809Leslie S Kean · Seattle Children'S Hospital · R01 · FY2017 · HL
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques -- (KEAN)
$672,809Leslie S Kean · Boston Children'S Hospital · R01 · FY2018 · HL
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques -- (KEAN)
$672,809Leslie S Kean · Boston Children'S Hospital · R01 · FY2020 · HL
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques -- (KEAN)
$672,809Leslie S Kean · Boston Children'S Hospital · R01 · FY2019 · HL
Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage
$672,803John S Gunn · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · AI
Risk Factors for Ischemic Stroke in Women
$672,679Kathryn M Rexrode · Brigham And Women'S Hospital · R01 · FY2024 · HL
RADIOTRACER R &D IN NUCLEAR MEDICINE AND NEUROSCIENCES
$672,673Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2002 · NS